These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10622361)

  • 1. Age at onset of dementia and age of menopause in women with Down's syndrome.
    Cosgrave MP; Tyrrell J; McCarron M; Gill M; Lawlor BA
    J Intellect Disabil Res; 1999 Dec; 43 ( Pt 6)():461-5. PubMed ID: 10622361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of dementia is associated with age at menopause in women with Down's syndrome.
    Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R
    Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials.
    Blackwood DH; St Clair DM; Muir WJ; Oliver CJ; Dickens P
    J Ment Defic Res; 1988 Dec; 32 ( Pt 6)():439-53. PubMed ID: 2976841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and host factors for dementia in Down's syndrome.
    Schupf N; Sergievsky GH
    Br J Psychiatry; 2002 May; 180():405-10. PubMed ID: 11983636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing dementia in adults with Down's syndrome.
    Prasher VP; Sachdeva N; Tarrant N
    Neurodegener Dis Manag; 2015; 5(3):249-56. PubMed ID: 26107323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence of cognitive decline in dementia in adults with Down's syndrome.
    Devenny DA; Krinsky-McHale SJ; Sersen G; Silverman WP
    J Intellect Disabil Res; 2000 Dec; 44 ( Pt 6)():654-65. PubMed ID: 11115020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Hanney M; Prasher V; Williams N; Jones EL; Aarsland D; Corbett A; Lawrence D; Yu LM; Tyrer S; Francis PT; Johnson T; Bullock R; Ballard C;
    Lancet; 2012 Feb; 379(9815):528-36. PubMed ID: 22236802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dementia scale for Down's syndrome.
    Huxley A; Prasher VP; Haque MS
    J Intellect Disabil Res; 2000 Dec; 44 ( Pt 6)():697-8. PubMed ID: 11115024
    [No Abstract]   [Full Text] [Related]  

  • 9. Age-related neuropsychological deficits in Down's syndrome.
    Thase ME; Tigner R; Smeltzer DJ; Liss L
    Biol Psychiatry; 1984 Apr; 19(4):571-85. PubMed ID: 6234031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Down's syndrome, AIDS and Alzheimer's disease?
    Regland B; Gottfries CG
    Med Hypotheses; 1992 May; 38(1):11-9. PubMed ID: 1535413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
    Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of dementia in Down's syndrome.
    Evenhuis HM
    Arch Neurol; 1990 Mar; 47(3):263-7. PubMed ID: 2138013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of digestive absorption in four cases of Down's syndrome. Down's syndrome, malnutrition, malabsorption, and Alzheimer's disease.
    Abalan F; Jouan A; Weerts MT; Solles C; Brus J; Sauneron MF
    Med Hypotheses; 1990 Jan; 31(1):35-8. PubMed ID: 2138242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
    Cutler NR; Heston LL; Davies P; Haxby JV; Schapiro MB
    Ann Intern Med; 1985 Oct; 103(4):566-78. PubMed ID: 2864010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protective effect of apolipoprotein E e2 allele on dementia in Down's syndrome.
    Tyrrell J; Cosgrave M; Hawi Z; McPherson J; O'Brien C; McCalvert J; McLaughlin M; Lawlor B; Gill M
    Biol Psychiatry; 1998 Mar; 43(6):397-400. PubMed ID: 9532343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.
    Deb S; Braganza J; Norton N; Williams H; Kehoe PG; Williams J; Owen MJ
    Br J Psychiatry; 2000 May; 176():468-72. PubMed ID: 10912224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of dementia in Down's syndrome: a preliminary report.
    Thase ME; Liss L; Smeltzer D; Maloon J
    J Ment Defic Res; 1982 Dec; 26 (Pt 4)():239-44. PubMed ID: 6221112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailable estradiol and age at onset of Alzheimer's disease in postmenopausal women with Down syndrome.
    Schupf N; Winsten S; Patel B; Pang D; Ferin M; Zigman WB; Silverman W; Mayeux R
    Neurosci Lett; 2006 Oct; 406(3):298-302. PubMed ID: 16926067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.